922170-67-0 Usage
Description
4-Bromo-2-methyl-6-iodoaniline, with the molecular formula C7H7BrIN and CAS number 29388-59-4, is a halogenated aniline derivative. It features a benzene ring with a bromine and iodine atom attached, as well as a methyl group, making it a versatile intermediate for chemical reactions and synthesis processes. Due to its toxic and potentially harmful properties, it is considered hazardous and should be handled with care.
Uses
Used in Pharmaceutical Industry:
4-Bromo-2-methyl-6-iodoaniline is used as a building block in organic synthesis for the production of pharmaceuticals. Its unique chemical structure allows it to be a key component in the development of various medications, contributing to the advancement of healthcare and treatment options.
Used in Agrochemical Industry:
In the agrochemical sector, 4-Bromo-2-methyl-6-iodoaniline is utilized as a precursor in the synthesis of agrochemicals. Its properties make it suitable for creating compounds that can be used in pest control, crop protection, and other agricultural applications, thereby supporting food production and security.
Used in Fine Chemicals Industry:
4-Bromo-2-methyl-6-iodoaniline is also employed in the production of other fine chemicals. Its versatility as a chemical intermediate enables its use in a wide range of applications, from specialty chemicals to advanced materials, further expanding its utility across various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 922170-67-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,2,1,7 and 0 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 922170-67:
(8*9)+(7*2)+(6*2)+(5*1)+(4*7)+(3*0)+(2*6)+(1*7)=150
150 % 10 = 0
So 922170-67-0 is a valid CAS Registry Number.
922170-67-0Relevant articles and documents
Preparation method of 5-bromo-7-methylindole
-
Paragraph 0061-0068; 0083-0090; 0105-0112; 0127-0134, (2021/07/01)
The invention discloses a preparation method of 5-bromo-7-methylindole. The structure of an intermediate corresponds to a formula V. The preparation method comprises the following steps: using 4-bromo-2-methylaniline as an initial raw material, and carryi
Target-Based Identification and Optimization of 5-Indazol-5-yl Pyridones as Toll-like Receptor 7 and 8 Antagonists Using a Biochemical TLR8 Antagonist Competition Assay
Knoepfel, Thomas,Nimsgern, Pierre,Jacquier, Sébastien,Bourrel, Marjorie,Vangrevelinghe, Eric,Glatthar, Ralf,Behnke, Dirk,Alper, Phil B.,Michellys, Pierre-Yves,Deane, Jonathan,Junt, Tobias,Zipfel, Géraldine,Limonta, Sarah,Hawtin, Stuart,Andre, Cedric,Boulay, Thomas,Loetscher, Pius,Faller, Michael,Blank, Jutta,Feifel, Roland,Betschart, Claudia
, p. 8276 - 8295 (2020/08/24)
Inappropriate activation of endosomal TLR7 and TLR8 occurs in several autoimmune diseases, in particular systemic lupus erythematosus (SLE). Herein, the development of a TLR8 antagonist competition assay and its application for hit generation of dual TLR7
ARYL, HETEROARY, AND HETEROCYCLIC PHARMACEUTICAL COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS
-
Page/Page column 638; 639, (2018/09/21)
Complement Factor D inhibitors, pharmaceutical compositions, and uses thereof, as well as processes for their manufacture are provided. The compounds provided include Formula I, Formula II, Formula III, Formula IV, and Formula V, or a pharmaceutically acceptable salt, prodrug, isotopic analog, N-oxide, or isolated isomer thereof, optionally in a pharmaceutically acceptable composition. The inhibitors described herein target Factor D and inhibit or regulate the complement cascade.
